(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USO DE CELIPROLOL NO TRATAMENTO DA SÍNDROME DE EHLERS-DANLOS TIPO VASCULAR EM MULHERES DURANTE A GRAVIDEZ E O PERÍODO PERIPARTO

ArquivadaInvention PatentPCT · EP2018085896

Application data

Number

112020012529

Type

Invention Patent

Filing

12/19/2018

Publication

11/24/2020

PCT

EP2018085896

Progress at the INPI

  1. Filing12/19/18
  2. Publication11/24/20
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 12/19/2018 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 06/14/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS

FR

U. P. (pessoa física)

FR

See this company's full portfolio

Inventors

A. B. (pessoa física)

FR

M. F. (pessoa física)

FR

X. J. (pessoa física)

FR

Technical data

Priority claims

EP

17306889.1 · 12/21/2017

US

16/184,903 · 11/08/2018

Abstract

A presente invenção refere-se ao uso de celiprolol ou um sal farmaceuticamente aceitável do mesmo para tratar a síndrome de Ehlers-Danlos tipo vascular em mulheres durante a gravidez e período periparto.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

06/14/2022

RPI 2684

Arquivamento - Art. 33 da LPI

#11.1

03/29/2022

RPI 2673

Adição na publicação

#15.35

12/07/2021

RPI 2657

Notificação de entrada na fase nacional - PCT

#1.3

11/24/2020

RPI 2603

Alteração de dados cadastrais

#1.1

10/20/2020

RPI 2598

Related

From the same holder

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.